BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Bausch Health Announces First Quarter 2024 Results Financial Results Adjusted EBITDA Pharmaceutical Industry Revenue Growth Bausch Health
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Bausch Health annonce ses résultats du premier trimestre 2024 Résultats Financiers EBITDA Ajusté Hausse Des Revenus Bausch Santé Industrie Pharmaceutique
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Electrovaya Schedules Q2-2024 Financial Results Release and Conference Call Lithium-ion Battery Conference Call Financial Announcement Electrovaya Q2-2024 Results
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Electrovaya prévoit la publication de ses résultats financiers du deuxième trimestre 2024 et une conférence téléphonique Conférence Téléphonique Electrovaya Annonce Financière Batterie Aux Ions Lithium Résultats Du T2-2024
BRIEF published on 05/02/2024 at 12:59, 1 year 10 months ago Apex Fundrock Limited Discloses Substantial Position in Tyman PLC Apex Fundrock Limited Financial Markets Shareholding Disclosure Chelverton Asset Management Tyman PLC
BRIEF published on 05/02/2024 at 12:59, 1 year 10 months ago Apex Fundrock Limited divulgue une position substantielle dans Tyman PLC Marchés Financiers Apex Fundrock Limitée Gestion D'actifs Chelverton Déclaration D'actionnariat Tyman PLC
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Planet 13 Holdings Schedules Q1 2024 Financial Results Release and Conference Call Financial Results Conference Call Cannabis Industry Planet 13 Holdings Q1 2024
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Planet 13 Holdings prévoit la publication des résultats financiers du premier trimestre 2024 et une conférence téléphonique Résultats Financiers Conférence Téléphonique Industrie Du Cannabis Planète 13 Avoirs T1 2024
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Moderna publie ses résultats financiers et ses progrès stratégiques pour le premier trimestre 2024 Résultats Financiers Technologie ARNm Développement De Vaccins Moderne Vaccin Contre Le VRS
Published on 03/11/2026 at 23:00, 2 hours 34 minutes ago Redwood AI Enhances Its Chemical Synthesis Platform with Industry-Grade Integrated Safety Functionality, Streamlining User Chemical Development Processes
Published on 03/11/2026 at 22:55, 2 hours 39 minutes ago Pathfinder Ventures Announces Closing of Parksville Refinancing and Extension of Private Placement
Published on 03/11/2026 at 19:00, 6 hours 34 minutes ago Worksport Announces Fourth Quarter and Full Year 2025 Earnings Date; Updated Financial Guidance and Path to Cash-Flow Positivity to Be Discussed
Published on 03/11/2026 at 21:30, 4 hours 4 minutes ago KPS CAPITAL PARTNERS TO ACQUIRE A CONTROLLING INTEREST IN JENNMAR
Published on 03/11/2026 at 18:19, 7 hours 15 minutes ago Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings
Published on 03/11/2026 at 18:11, 7 hours 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/11/2026 at 18:05, 7 hours 29 minutes ago Ridgewood Infrastructure Announces Sale of APP
Published on 03/11/2026 at 20:05, 5 hours 29 minutes ago CDA - Compte rendu de l'AG et du Conseil d'administration
Published on 03/11/2026 at 18:30, 7 hours 4 minutes ago Filing of the 2025 TF1 Universal Registration Document
Published on 03/11/2026 at 18:30, 7 hours 4 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025 de TF1
